SCHEMBL1823116

SCHEMBL1823116

COC(=O)C(O)c1ccccc1OS(=O)(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
LMNA P02545 4/20 0.46
HTT P42858 3/20 0.46
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 1/20 0.42
EYA2 O00167 1/20 0.42
GAA P10253 1/20 0.42
HSD11B1 P28845 1/20 0.40
HSD17B3 P37058 1/20 0.40
METAP2 P50579 1/20 0.40
METAP1 P53582 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KMT2A Q03164 1/20 0.39
DHODH Q02127 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1822857 0.91 LMNA (0.49) ALDH1A1LMNAHTTMAPTGAA
SCHEMBL2830139 0.86 ALDH1A1 (0.46) ALDH1A1LMNAHTTMAPTSMN1; SMN2
SCHEMBL1823780 0.85 MAPT (0.48) ALDH1A1LMNAHTTMAPTSMN1; SMN2
SCHEMBL1824348 0.84 ALDH1A1 (0.45) ALDH1A1LMNAHTTMAPTSMN1; SMN2
SCHEMBL1822261 0.84 CA1 (0.39) ALDH1A1HTTKDM4EL3MBTL1KMT2A
SCHEMBL1826101 0.83 ALDH1A1 (0.44) ALDH1A1LMNAHTTMAPTSMN1; SMN2
SCHEMBL1827636 0.82 MAPT (0.48) ALDH1A1LMNAHTTMAPTSMN1; SMN2
SCHEMBL2831657 0.82 SMN1; SMN2 (0.47) ALDH1A1LMNAHTTMAPTSMN1; SMN2
SCHEMBL1824013 0.81 ALDH1A1 (0.45) ALDH1A1LMNAHTTMAPTSMN1; SMN2
SCHEMBL1827233 0.80 ALDH1A1 (0.50) ALDH1A1LMNAHTTMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ALDH1A1 1099/4885LMNA 1802/4885HTT 4365/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 ALDH1A1 1440/4885LMNA 1130/4885HTT 3582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.